Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block in Acute Postherniorrhaphy Pain

NCT05158647 is registered in ClinicalTrials.gov with Abdelrady S Ibrahim, MD as lead sponsor.

NCT NCT05158647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block in Acute Postherniorrhaphy Pain
Lead sponsor
Abdelrady S Ibrahim, MD
Phase
Phase 2
Overall status
Completed
Start date
August 12, 2018
Completion date
April 21, 2020
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

magnesium sulfate causing adverse effects in therapeutic use